Lubeluzole (Prosynap) is a drug which acts as an indirect NMDA antagonist. It inhibits the release of glutamate inhibits nitric oxide synthesis and blocks calcium and sodium gated ion channels. It has neuroprotective effects particularly in hypoxic conditions and was developed for the treatment of stroke.
This page contains content from the copyrighted Wikipedia article "Lubeluzole"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
